Study #2017-0591
A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients
MD Anderson Study Status
Not Accepting
Treatment Agent
Dexamethasone
Description
This phase II trial studies how well dexamethasone works in controlling dyspnea in patients with cancer. Dexamethasone may help control dyspnea (shortness of breath) and improve lung function and quality of life in cancer patients.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Dyspnea, Malignant Neoplasm
Study phase:
Phase II
Physician name:
David Hui
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-844-580-2777
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.